河北医科大学学报 ›› 2025, Vol. 46 ›› Issue (2): 202-207.doi: 10.3969/j.issn.1007-3205.2025.02.013

• • 上一篇    下一篇

MiR-1-3p在VEGF/Notch信号通路介导青光眼模型视网膜神经节细胞凋亡的机制研究

  

  1. 四川省江油市九〇三医院眼科,四川 江油 621700

  • 出版日期:2025-02-25 发布日期:2025-02-27
  • 作者简介:顾丹(1986-),女,四川绵阳人,四川省江油市九〇三医院主治医师,医学学士,从事眼科疾病诊治研究。
  • 基金资助:
    四川省医学(青年创新)科研课题立项(S21207)

Mechanism of MiR-1-3p in apoptosis of retinal ganglion cells in glaucoma rats via VEGF/Notch signaling pathway

  1. Department of Ophthalmology, the 903rd Hospital of Jiangyou City, Sichuan Province, Jiangyou 621700, China

  • Online:2025-02-25 Published:2025-02-27

摘要: 目的 探讨miR-1-3p对青光眼大鼠视网膜神经节细胞凋亡的影响以及其调节机制。
方法 将36只1月龄SPF级SD大鼠进行适应性饲喂1周,之后采用随机数字表法均分为正常组、模型组和miR-1-3p拮抗组(每组12只)。其中,正常组的大鼠未进行任何处理。模型组的大鼠构建青光眼模型,术后每日腹腔注射无菌生理盐水0.2 mL,连续干预7 d。miR-1-3p拮抗组的大鼠构建青光眼模型,术后每日腹腔注射3 μmol/L的miR-1-3p拮抗剂0.2 mL,连续干预7 d。在青光眼模型造模结束及最后一次治疗干预时测量大鼠眼压。利用蛋白质免疫印迹法测定各组大鼠视网膜组织中Notch1和Notch2的水平。利用酶联免疫吸附试验(enzyme-linked immunosorbent assay,ELISA)检测血管内皮生长因子(vascular endothelial growth factor,VEGF)含量。利用qRT-PCR试验测定各组大鼠视网膜组织中VEGF、Notch1和Notch2 mRNA表达水平。利用原位末端标记法(TdT-mediated biotinylated-dUTP nick end labeling,TUNEL)检测试剂盒测定细胞凋亡情况。
结果 造模结束时模型组和miR-1-3p拮抗组的眼压均显著高于正常组(P<0.05)。最后一次治疗干预结束时,miR-1-3p拮抗组的眼压显著低于模型组(P<0.05)。模型组视网膜组织中VEGF水平与Notch1和Notch2蛋白表达水平显著高于正常组(P<0.05)。与模型组相比,miR-1-3p拮抗组视网膜组织中VEGF水平与Notch1和Notch2蛋白表达水平显著降低(P<0.05)。模型组视网膜组织中VEGF、Notch1和Notch2 mRNA表达水平和细胞凋亡水平显著高于正常组(P<0.05)。与模型组相比,miR-1-3p拮抗组视网膜组织中VEGF、Notch1和Notch2 mRNA表达水平和细胞凋亡水平显著降低(P<0.05)。
结论 MiR-1-3p通过促进VEGF/Notch信号通路促进青光眼大鼠视网膜神经节细胞凋亡,是治疗青光眼的潜在分子靶标。


关键词: 青光眼, 视网膜神经节细胞, 细胞凋亡

Abstract: Objective To investigate the effect of miR-1-3p on apoptosis of retinal ganglion cells in glaucoma rats and its regulatory mechanism. 
Methods Thirty-six one-month-old SPF SD rats were given adaptive feeding for one week, and then divided into normal group (n=12), model group (n=12) and miR-1-3p antagonistic group (n=12) by random number table method. The normal group did not receive any treatment. The rats in the model group were used to construct glaucoma model, and 0.2 mL sterile saline was injected intraperitoneally every day for 7 days. The rats in the miR-1-3p antagonist group were used to construct glaucoma model, and 0.2 mL of 3 μmol/L miR-1-3p antagonist was injected intraperitoneally every day after surgery for continuous intervention for 7 days. Intraocular pressure (IOP) was measured at the end of glaucoma modeling and the last intervention. The levels of Notch1 and Notch2 in the retinal tissues of each group were measured by Western blotting, and vascular endothelial growth factor (VEGF) content was detected by enzyme-linked immunosorbent assay (ELISA). The mRNA expression levels of VEGF, Notch1 and Notch2 in retinal tissues of rats were determined by qRT-PCR, and apoptosis was determined by TdT-mediated biotinylated-dUTP nick end labeling (TUNEL) assay. 
Results At the end of modeling, the IOP of model group and miR-1-3p antagonist group was significantly higher than that of normal group (P<0.05). At the end of the last intervention, the IOP of miR-1-3p antagonist group was significantly lower than that of model group (P<0.05). VEGF levels and Notch1 and Notch2 protein expression levels in retinal tissues of model group were significantly higher than those of normal group (P<0.05). Compared with the model group, VEGF levels and Notch1 and Notch2 protein expression levels in retinal tissues of miR-1-3p antagonistic group were significantly decreased (P<0.05). The mRNA expression levels of VEGF, Notch1, Notch2 and apoptosis levels in retinal tissues in model group were significantly higher than those in normal group (P<0.05). Compared with the model group, mRNA expression levels of VEGF, Notch1, Notch2 and apoptosis levels in retinal tissues of miR-1-3p antagonist group were significantly decreased (P<0.05). 
Conclusion MiR-1-3p promotes apoptosis of retinal ganglion cells in glaucoma rats by promoting VEGF/Notch signaling pathway, which is a potential molecular target for the treatment of glaucoma. 


Key words: glaucoma, retinal ganglion cells, apoptosis